glp-1 agonist alzheimer's Microdosing, Brain Health & Prevention Weight-Loss Drugs May Reduce Buildup

Oral drops: Compounding pharmacies produce oral GLP drops with the same active ingredients as the brand name GLP-1s, but they are not approved by the FDA

The case settled in March 2026: Novo dropped the lawsuit in exchange for Hims agreeing to transition its platform entirely to authorized, branded semaglutide products and to cease all advertising of compounded GLP-1 alternatives

We know that patients who are treated with GLP-1RA are much less likely to die from any cause than patients treated with DPP-IV inhibitors and sulfonylureas

Most pharmacokinetic studies assessing the brain uptake of incretin mimetics have been conducted in animals, and translating these findings to human subjects and clinical outcomes remains uncertain

C.AtkinS